BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 6989300)

  • 21. Western blot and indirect fluorescent antibody testing for antibodies reactive with Ehrlichia canis in sera from apparently healthy dogs in Zimbabwe.
    Matthewman LA; Kelly PJ; Mahan SM; Semu D; Tagwira M; Bobade PA; Brouqui P; Mason PR; Raoult D
    J S Afr Vet Assoc; 1993 Sep; 64(3):111-5. PubMed ID: 8176682
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of the subclinical phase of ehrlichiosis in dogs.
    Codner EC; Farris-Smith LL
    J Am Vet Med Assoc; 1986 Jul; 189(1):47-50. PubMed ID: 3733499
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Longitudinal quantification of Ehrlichia canis in experimental infection with comparison to natural infection.
    Baneth G; Harrus S; Ohnona FS; Schlesinger Y
    Vet Microbiol; 2009 May; 136(3-4):321-5. PubMed ID: 19128893
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Kinetics of antibody response to Ehrlichia canis assayed by the indirect fluorescent antibody method.
    Weisiger RM; Ristic M; Huxsoll DL
    Am J Vet Res; 1975 May; 36(5):689-94. PubMed ID: 49162
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Autologous lymphocyte-mediated cytotoxicity against monocytes in canine ehrlichiosis.
    Kakoma I; Carson CA; Ristic M; Huxsoll DL; Stephenson EH; Nyindo MB
    Am J Vet Res; 1977 Oct; 38(10):1557-9. PubMed ID: 931138
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antisperm responses in male dogs with chronic Brucella canis infections.
    George L; Carmichael L
    Am J Vet Res; 1984 Feb; 45(2):274-81. PubMed ID: 6231870
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of plasmapheresis and chemotherapy for treatment of monoclonal gammopathy associated with Ehrlichia canis infection in a dog.
    Matus RE; Leifer CE; Hurvitz AI
    J Am Vet Med Assoc; 1987 May; 190(10):1302-4. PubMed ID: 3583884
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Platelet aggregation studies in dogs with acute Ehrlichia platys infection.
    Gaunt SD; Baker DC; Babin SS
    Am J Vet Res; 1990 Feb; 51(2):290-3. PubMed ID: 2301842
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Attempted transmission of Ehrlichia canis by Rhipicephalus sanguineus after passage in cell culture.
    Mathew JS; Ewing SA; Barker RW; Fox JC; Dawson JE; Warner CK; Murphy GL; Kocan KM
    Am J Vet Res; 1996 Nov; 57(11):1594-8. PubMed ID: 8915436
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polymerase chain reaction evidence of Ehrlichia chaffeensis, an etiologic agent of human ehrlichiosis, in dogs from southeast Virginia.
    Dawson JE; Biggie KL; Warner CK; Cookson K; Jenkins S; Levine JF; Olson JG
    Am J Vet Res; 1996 Aug; 57(8):1175-9. PubMed ID: 8836370
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytokine responses in dogs infected with Ehrlichia canis Oklahoma strain.
    Tajima T; Rikihisa Y
    Ann N Y Acad Sci; 2005 Dec; 1063():429-32. PubMed ID: 16481554
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunological studies with aortic and venous tissue antigens. III. Examination of cell-mediated and humoral immune response induced by human vascular antigens.
    Horvath M; Alfoldy P; Onody K; Petranyi G; Szondy E; Gero S
    Paroi Arterielle; 1978; 4(2):89-95. PubMed ID: 418373
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Experimental Infections in dogs with Ehrlichia canis strain Borgo 89.
    Jouret-Gourjault S; Parzy D; Davoust B
    Ann N Y Acad Sci; 2006 Oct; 1078():470-5. PubMed ID: 17114756
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Progressive myelopathy in older German shepherd dogs. II. Presence of circulating suppressor cells.
    Waxman FJ; Clemmons RM; Hinrichs DJ
    J Immunol; 1980 Mar; 124(3):1216-22. PubMed ID: 6444648
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Humoral and cell-mediated immune competence of high-cancer-risk canine breeds.
    Dorn CR; Heuschele WP
    Am J Vet Res; 1978 Dec; 39(12):1932-5. PubMed ID: 373522
    [No Abstract]   [Full Text] [Related]  

  • 36. Serologic prevalence of Dirofilaria immitis, Ehrlichia canis, and Borrelia burgdorferi infections in Brazil.
    Labarthe N; de Campos Pereira M; Barbarini O; McKee W; Coimbra CA; Hoskins J
    Vet Ther; 2003; 4(1):67-75. PubMed ID: 12756637
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum hyperviscosity syndrome associated with Ehrlichia canis infection in a dog.
    Hoskins JD; Barta O; Rothschmitt J
    J Am Vet Med Assoc; 1983 Nov; 183(9):1011-2, 964. PubMed ID: 12002576
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Application of 10% imidacloprid/50% permethrin to prevent Ehrlichia canis exposure in dogs under natural conditions.
    Otranto D; Paradies P; Testini G; Latrofa MS; Weigl S; Cantacessi C; Mencke N; de Caprariis D; Parisi A; Capelli G; Stanneck D
    Vet Parasitol; 2008 May; 153(3-4):320-8. PubMed ID: 18359166
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytokine gene expression by peripheral blood leukocytes in dogs experimentally infected with a new virulent strain of Ehrlichia canis.
    Unver A; Huang H; Rikihisa Y
    Ann N Y Acad Sci; 2006 Oct; 1078():482-6. PubMed ID: 17114759
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of Ehrlichia canis by PCR in different tissues obtained during necropsy from dogs surveyed for naturally occurring canine monocytic ehrlichiosis.
    Gal A; Loeb E; Yisaschar-Mekuzas Y; Baneth G
    Vet J; 2008 Feb; 175(2):212-7. PubMed ID: 17368942
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.